Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice. [PDF]
Zhuge A +9 more
europepmc +1 more source
Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor. [PDF]
Jamal F +11 more
europepmc +1 more source
Correction: Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand. [PDF]
Yu J, Yang K, Zheng J, Zhao W, Sun X.
europepmc +1 more source
OTU-14 Positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH [PDF]
Zobair M. Younossi +9 more
openalex +1 more source
Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluation. [PDF]
Tran CP, Kim JJ, Feld JJ, Wong WW.
europepmc +1 more source
Von der Pathophysiologie zur Therapie chronisch cholestatischer Lebererkrankungen [PDF]
Hohenester, Simon
core

